Amundi Charles River Laboratories International, Inc. Transaction History

Amundi

$276 Billion
Q2 2025

A detailed history of Amundi transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Amundi holds 226,257 shares of CRL stock, worth $44.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

226,257

Previous 16,347 1284.09%

Holding current value

$44.2 Million

Previous $2.46 Million 1295.49%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$99.75 - $151.89 $20.9 Million - $31.9 Million	209,910 Added 1284.09%	226,257 $34.3 Million
Q1 2025 May 15, 2025	SELL	$150.52 - $190.14 $8.12 Million - $10.3 Million	-53,919 Reduced 76.74%	16,347 $2.46 Million
Q4 2024 Feb 07, 2025	BUY	$178.58 - $220.69 $2.96 Million - $3.66 Million	16,599 Added 30.93%	70,266 $13 Million
Q3 2024 Nov 13, 2024	SELL	$187.96 - $245.29 $872,698 - $1.14 Million	-4,643 Reduced 7.96%	53,667 $10.6 Million
Q2 2024 Aug 14, 2024	BUY	$206.39 - $268.73 $125,485 - $163,387	608 Added 1.05%	58,310 $12 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $2.62 Million - $3.52 Million	-12,888 Reduced 18.26%	57,702 $15.6 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $4.26 Million - $6.19 Million	25,896 Added 57.94%	70,590 $16.7 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $4.38 Million - $4.91 Million	-22,543 Reduced 33.53%	44,694 $8.76 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $20.1 Million - $23 Million	-109,173 Reduced 61.89%	67,237 $14.1 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $12.3 Million - $16.6 Million	63,983 Added 56.91%	176,410 $35.6 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $5.08 Million - $6.44 Million	-25,753 Reduced 18.64%	112,427 $24.5 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $10.1 Million - $13.8 Million	-55,123 Reduced 28.52%	138,180 $29.8 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $10 Million - $14.8 Million	49,086 Added 34.04%	193,303 $40.7 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $1.26 Million - $1.78 Million	4,915 Added 3.53%	144,217 $43.6 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $18.1 Million - $23.1 Million	-51,448 Reduced 26.97%	139,302 $49 Million
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $13.1 Million - $16.1 Million	35,082 Added 22.54%	190,750 $78.7 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $45.8 Million - $57.9 Million	155,668 New	155,668 $57.6 Million

Others Institutions Holding CRL

# of Institutions

630

Shares Held

52.5M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.93B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account